Literature DB >> 15479157

The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter.

Daman Kumari1, Andrei Gabrielian, David Wheeler, Karen Usdin.   

Abstract

Expansion of a CGG.CCG-repeat tract in the 5'-untranslated region of the FMR1 (Fragile X mental retardation 1) gene causes its aberrant transcription. This produces symptoms ranging from premature ovarian failure and Fragile X associated tremor and ataxia syndrome to FMR syndrome, depending on the size of the expansion. The promoter from normal alleles shows four protein-binding regions in vivo. We had previously shown that in mouse brain extracts two of these sites are bound by USF1/USF2 (upstream stimulatory factors 1 and 2) heterodimers and NRF-1 (nuclear respiratory factor-1). We also showed that these sites are involved in the positive regulation of FMR1 transcription in neuronally derived cells. In the present study, we show that Sp1 (specificity protein 1) and Sp3 are also strong positive regulators of FMR1 promoter activity. We also show that, like Sp1 and E-box-binding proteins such as USF1 and USF2, NRF-1 causes DNA bending, in this case producing a bend of 57 degrees towards the major groove. The combined effect of the four protein-induced bends on promoter geometry is the formation of a highly compact arch-like structure in which the 5' end of the promoter is brought in close proximity to the 3' end. We had previously shown that while point mutations in the GC-boxes decrease promoter activity, deletion of either one of them leads to an increase in promoter activity. We can reconcile these observations with the positive effect of Sp1 and Sp3 if protein-induced bending acts, at least in part, to bring together distally spaced factors important for transcription initiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15479157      PMCID: PMC1134794          DOI: 10.1042/BJ20041124

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.

Authors:  F Tassone; R J Hagerman; A K Taylor; P J Hagerman
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

2.  Involvement of NF-Y and Sp1 in basal and cAMP-stimulated transcriptional activation of the tryptophan hydroxylase (TPH ) gene in the pineal gland.

Authors:  F Côté; N Schussler; S Boularand; A Peirotes; E Thévenot; J Mallet; G Vodjdani
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

3.  Dominant effect of protein charge rather than protein shape in apparent DNA bending by engineered bZIP domains.

Authors:  Philip R Hardwidge; Jason D Kahn; L James Maher
Journal:  Biochemistry       Date:  2002-07-02       Impact factor: 3.162

4.  Fragile X syndrome: of POF and premutations.

Authors:  J Macpherson; A Murray; J Webb; P Jacobs
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

5.  Transcription of the FMR1 gene in individuals with fragile X syndrome.

Authors:  F Tassone; R J Hagerman; W D Chamberlain; P J Hagerman
Journal:  Am J Med Genet       Date:  2000

6.  Sp1 acts as a repressor of the human adenine nucleotide translocase-2 (ANT2) promoter.

Authors:  A Zaid; Z Hodny; R Li; B D Nelson
Journal:  Eur J Biochem       Date:  2001-11

7.  Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome.

Authors:  D Kumari; K Usdin
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

8.  Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.

Authors:  James A Brunberg; Sebastien Jacquemont; Randi J Hagerman; Elizabeth M Berry-Kravis; Jim Grigsby; Maureen A Leehey; Flora Tassone; W Ted Brown; Claudia M Greco; Paul J Hagerman
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

9.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

Authors:  C M Greco; R J Hagerman; F Tassone; A E Chudley; M R Del Bigio; S Jacquemont; M Leehey; P J Hagerman
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

10.  Dynein light chain interacts with NRF-1 and EWG, structurally and functionally related transcription factors from humans and drosophila.

Authors:  R P Herzig; U Andersson; R C Scarpulla
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  11 in total

1.  NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2).

Authors:  Lata Mahishi; Karen Usdin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

2.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

3.  The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2010-09-14       Impact factor: 6.150

4.  Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males.

Authors:  Stephen C Collins; Steven M Bray; Joshua A Suhl; David J Cutler; Bradford Coffee; Michael E Zwick; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

5.  Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging.

Authors:  Kanchan Singh; S Prasad
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

6.  Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse.

Authors:  Pankaj Gaur; S Prasad
Journal:  Mol Biol Rep       Date:  2014-07-12       Impact factor: 2.316

Review 7.  Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.

Authors:  Kaumudi Bhawe; Deodutta Roy
Journal:  Cell Oncol (Dordr)       Date:  2018-07-25       Impact factor: 6.730

8.  Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain.

Authors:  S Prasad; Kanchan Singh
Journal:  Neurochem Res       Date:  2007-12-14       Impact factor: 3.996

9.  The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors.

Authors:  Karen T Smith; Robert D Nicholls; Daniel Reines
Journal:  Nucleic Acids Res       Date:  2006-02-25       Impact factor: 16.971

10.  The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease.

Authors:  Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.